JPS52148062A - Steroids - Google Patents

Steroids

Info

Publication number
JPS52148062A
JPS52148062A JP6287977A JP6287977A JPS52148062A JP S52148062 A JPS52148062 A JP S52148062A JP 6287977 A JP6287977 A JP 6287977A JP 6287977 A JP6287977 A JP 6287977A JP S52148062 A JPS52148062 A JP S52148062A
Authority
JP
Japan
Prior art keywords
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6287977A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6244560B2 (enExample
Inventor
Reon Rebinsukii Henrii
Torabii Haushiyangu
Furanshisu Mouroo Daanii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS52148062A publication Critical patent/JPS52148062A/ja
Publication of JPS6244560B2 publication Critical patent/JPS6244560B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6287977A 1976-06-04 1977-05-31 Steroids Granted JPS52148062A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23169/76A GB1544642A (en) 1976-06-04 1976-06-04 9,11-epoxy steroids and synthesis of corticosteroids therefrom

Publications (2)

Publication Number Publication Date
JPS52148062A true JPS52148062A (en) 1977-12-08
JPS6244560B2 JPS6244560B2 (enExample) 1987-09-21

Family

ID=10191289

Family Applications (2)

Application Number Title Priority Date Filing Date
JP6287977A Granted JPS52148062A (en) 1976-06-04 1977-05-31 Steroids
JP61238159A Pending JPS62142197A (ja) 1976-06-04 1986-10-08 ステロイド類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61238159A Pending JPS62142197A (ja) 1976-06-04 1986-10-08 ステロイド類

Country Status (3)

Country Link
JP (2) JPS52148062A (enExample)
CA (1) CA1086715A (enExample)
GB (1) GB1544642A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
PT2805720T (pt) 2008-05-28 2019-09-23 Reveragen Biopharma Inc Moduladores esteroides não hormonais de nf-kb para tratamento de uma doença
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
CN112851734B (zh) * 2019-11-27 2024-02-06 重庆华邦胜凯制药有限公司 一种二丙酸倍他米松的制备方法
CN113024622A (zh) * 2019-12-24 2021-06-25 天津天药药业股份有限公司 一种连续生产的甾体溴羟工艺
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法
CN113562912B (zh) * 2021-06-28 2023-04-07 佳尔科生物科技南通有限公司 一种处理螺内酯中间体生产废水的方法

Also Published As

Publication number Publication date
JPS62142197A (ja) 1987-06-25
JPS6244560B2 (enExample) 1987-09-21
CA1086715A (en) 1980-09-30
GB1544642A (en) 1979-04-25

Similar Documents

Publication Publication Date Title
NZ183775A (en) Anaesthetic steroids
CS40277A2 (en) Zarovzdorna soucast pro nadoby obsahujici taveninu kovu
GB1547127A (en) Cyclopentan-u-amines
AU2726877A (en) Benzofuranyl-benzimidazoles
JPS5389068A (en) Energyysaving means
AU2142677A (en) Steroids
CS193582B2 (en) Fingicide means
JPS52148062A (en) Steroids
GB1554662A (en) Polyhydroxyphenylchromanones
ZA775800B (en) Polyhalogenated steroids
AU1309176A (en) Fire-barriers
AU512101B2 (en) 19-oxygenated steroids
CS886177A2 (en) Nabijeci zarizeni pro automatickou strelnou zbran
GB1548322A (en) 3-phenyl-7-nv-triazol-2-yl)-coumarins
JPS5327228A (en) Panel
AU2378777A (en) Amino - alkoxyalkanes
GB1537670A (en) De-tinning
GB1546029A (en) N-hydrocarbyloxymethyl-alpha-haloacetanilides
GB1551473A (en) Arylmalonamidomethoxycephalosporins
ZA777725B (en) Indicia-display panel
GB1541426A (en) Turf-treatment means
AU2664077A (en) Frequency-synthesizer-tuner
AU2710877A (en) Benzodioxepins
JPS5283729A (en) Steroids
JPS5283448A (en) Steroid